United States · FDA National Drug Code directory
Cystografin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0270-0149_6b067ea9-50b4-0ec7-1f1c-e07b00faced4
- Product NDC
- 0270-0149
- Form
- INJECTION, SOLUTION
- Composition / generic term
- diatrizoate meglumine
- Labeler
- BRACCO DIAGNOSTICS INC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19701103
- Source listing expiry
- 20261231
Source-listed ingredients
- DIATRIZOATE MEGLUMINE — 300 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BOTTLE in 1 PACKAGE (0270-0149-57) / 300 mL in 1 BOTTLE · 0270-0149-57
- 10 BOTTLE in 1 PACKAGE (0270-0149-60) / 100 mL in 1 BOTTLE · 0270-0149-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →